CN1250368A - Mouthwash composition - Google Patents

Mouthwash composition Download PDF

Info

Publication number
CN1250368A
CN1250368A CN98803284A CN98803284A CN1250368A CN 1250368 A CN1250368 A CN 1250368A CN 98803284 A CN98803284 A CN 98803284A CN 98803284 A CN98803284 A CN 98803284A CN 1250368 A CN1250368 A CN 1250368A
Authority
CN
China
Prior art keywords
hibitane
compositions
pvp
mutually
stomatology
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98803284A
Other languages
Chinese (zh)
Inventor
S·E·亚历山大
J·瓦德斯莱
M·A·维克斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of CN1250368A publication Critical patent/CN1250368A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43Guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A two phase mouthwash composition is described comprising chlorhexidine and polyvinyl pyrrolidone.

Description

Mouthwash composition
The present invention relates to mouthwash composition, particularly the compositions of cation antibacterial hibitane.
WO93/16681 discloses a kind of oral hygiene composition, comprises cation antibacterial such as hibitane and detergent polyvinyl pyrrolidone (PVP).
Have now found that the biphase hibitane/PVP collutory with specific pH scope demonstrates enhanced hibitane effect.
Therefore, first aspect the invention provides and comprises biphase mouthwash composition; First comprises on hibitane or its a kind of stomatology acceptable carrier or excipient on the acceptable acid-addition salts and a kind of stomatology mutually, and second comprises acceptable carrier or excipient on PVP and a kind of stomatology mutually; The biphase maintenance before use separately, mix the back they pH is provided is 6 to 10 single-phase composite.
Using preceding separately is useful with hibitane with PVP mutually, can be lowered because have been found that hibitane its effect after the PVP long term store.
Hibitane mutually and PVP pH scope mutually should be after mixing, obtain 6.0-10.0, preferably 6.0-9.0, more preferably 6.0-7.0 is as 6.2 pH.
Can will wait the hibitane of weight to be mixed mutually easily before using with PVP.
The initial pH of hibitane phase is fit to be not more than 6, and this has the advantage of the extended storage stability that improves hibitane.
The initial pH of preferred hibitane phase is 3.0-6.0,5.0-5.9 5.5-5.9 for example more preferably.
The matched pH of PVP is 6.0-10.0, be preferably 6.0-9.0,6.0-8.0 more preferably.
Thereby preferred described PVP comprises acceptable buffer on a kind of stomatology or pH regulator agent mutually obtains required pH mixing the back mutually with hibitane.
The example of acceptable buffer agent and pH regulator agent comprises a kind of alkali such as sodium hydroxide or a kind of acid such as acetic acid, gluconic acid, tartaric acid, citric acid, lactic acid or phosphoric acid or a kind of its soluble-salt on the stomatology.These materials can use separately, also can mix use.A kind of preferred buffer is a sodium acetate.
For required buffering effect is provided, described buffer or pH regulator agent should exist with enough amounts, and the scope that is fit to is the 0.01-10% of described composition weight, preferred 0.1-2%.
Compositions of the present invention can be packaged in the container such as bottle or pipe with two chambers that separate described each phase, and described container has a dispersing nozzle to be disperseed for the control of described each phase before using and compatibly mix.Perhaps described compositions can be packaged in the bag (sachet) with two Room, and two Room separate by a brittle sealing material, before using seal dissepiment is broken to allow biphasely to mix in bag.
Perhaps also can be packaged in the independent container biphase, desirable aequum is respectively disperseed mutually before mixing and the use.
Be used for that polyvinyl pyrrolidone of the present invention is fit to have at least 5000, the mean molecule quantity of for example 5000-100000, preferably have the mean molecule quantity of 5000-50000.Having mean molecule quantity and be 10000,30000 and 40000 polyvinyl pyrrolidone can be respectively available from Sigma Chemical Co., GAF Corporation and Sigma ChemicalCo..The suitable amount of polyvinyl pyrrolidone be described composition weight at least 0.5%, be preferably 0.5-30%, 0.5-25% more preferably, favourable scope is 1-15%.
On hibitane or a kind of its stomatology the suitable amount of acceptable acid-addition salts be described composition weight 0.005-10%, be preferably 0.01-5%, 0.01-2% more preferably.
The salt of the hibitane that is suitable for is included in 20 ℃ of salt with the dissolubility of at least 0.005% (weight/volume), comprises digluconate, diformate, diacetin, dipropionate, two hydriodates, nicotinium dihydrochloride, lactyl-lactic acid salt, dinitrate, sulfate and tartrate.Wherein digluconate, diacetin and nicotinium dihydrochloride are preferred.
Compositions of the present invention also can usefully comprise a kind of ion fluorochemical.The ion fluorochemical that is suitable for for example comprises that fluoride salt such as amine fluoride and alkali metal fluoride salt such as sodium fluoride and mono-fluor phosphate are such as alkali metal mono-fluor phosphate such as sodium monofluorophosphate.Described ion fluorochemical suitably is blended in the described compositions, so that the fluorion of 50-2000ppm, preferred 100-500ppm to be provided.
Compositions of the present invention is suitable for preferably comprising in a kind of aqueous solution or a kind of water/alcoholic solution as a kind of surfactant of carrier component and the wetting agent of choosing any one kind of them.
It will be understood by those skilled in the art that the antibacterial activity in order to ensure hibitane is not reduced by reality, can select compatible component to be included on the stomatology in acceptable carrier or the excipient.Therefore, should preferably avoid required anionic species, because this material can cause its inactivation by forming insoluble precipitation with hibitane.Therefore, anion surfactant and anionic wetting agent preferably need not and agree with using non-anion homologue such as nonionic, cation or amphoteric surfactant and nonionic wetting agent.
The ionic surfactant pack that is suitable for for example draw together polyethoxylated sorbitol ester, particularly polyethoxylated sorbitol one ester such as PEG (40) two isostearic acid Isosorbide Dinitrates and by ICI with commodity ' Tween ' product sold by name; The condensation polymer of oxirane and expoxy propane (poloxamers) such as BASF-Wyandotte is with commodity ' Pluronic ' product sold by name; The condensation substance of propylene glycol; Polyethoxylated hydrogenated castor such as cremophors; And fatty acid esters of sorbitan.
The amphoteric surfactant that is suitable for comprises that for example the long-chain imidazolidine derivatives is such as being called ' Miranol C2M ' product sold by Miranol with commodity; Long-chain alkyl lycine is such as being called ' Empigen BB ' product sold and chain alkyl amido alkyl betanin such as cocamidopropyl betaine and its mixture by Albright+Wilson with commodity.
The cationic surfactant that is fit to comprises the D with the ethyl-N-cocoyl-L-arginine ester of commodity CAE sale by name by Ajinomoto Co.Inc., L-2-pyrrolidone-5-carboxylic acid salt.
Preferred surfactants comprises non-ionic poloxamers and many ethoxylated hydrogenated castor oils.
Have been found that if the pH of mixed phase at 6-10, preferably at 6-8, the compatibility of so this surfactant and hibitane further strengthens.
The amount of described surfactant be preferably described composition weight 0.005-5%, be preferably 0.005-1%, 0.01-0.5% more preferably.
Be applicable to that the wetting agent in the compositions of the present invention comprises for example glycerol, sorbitol, propylene glycol or Polyethylene Glycol or its mixture.The amount of described wetting agent can be described composition weight 5-70%, be preferably 5-30%, 5-20% more preferably.
Other material that can join if desired in the described compositions has for example sweeting agent, fumet, coloring agent, preservative agent and emulsifying agent.
Described PVP fit comprises a kind of sweeting agent such as saccharin sodium, preferably itself and hibitane is kept separating mutually the unnecessary precipitation of hibitane when preventing long term store according to this/glucide coordination compound.
Can be according to preparation of compositions of the present invention by its each component is mixed and when needed its pH regulator carried out to desirable value then in required ratio and by any order easily.
Can be used for reducing or eliminating the stain that normally is accompanied by the appearance of use hibitane according to compositions of the present invention.
Therefore, on the other hand, the invention provides the defined mouthwash composition that is used for the treatment of of a kind of preamble, especially for the treatment of anti-speckle, preventing decayed tooth, anti-calculus and/or periodontal disease (comprising anti-gingivitis).
The present invention now illustrates with reference to the following example.
Embodiment 1 hibitane collutory
Composition %w/w Hibitane phase %w/w PVP phase %w/w
PVP - 15.000
Saccharin sodium - 0.104
Sodium acetate - 1.400
The hibitane gluconate 0.400 -
Glycerol 10.000 -
Dye solution 0.100 0.100
Ethanol 5.000 8.000
Cremophor?RH60 * 0.200 0.250
Flavored oils 0.120 0.120
Deionized water 84.180 75.026
Altogether 100.00 100.00
Mixing back pH is 6.20 Initial pH is 5.90 Initial pH is 6.30
*Cremophor RH60 is a kind of polyethoxylated hydrogenated castor that contains average 60 ethoxy units in the polyethoxylated chain.
Embodiment 2 pH are to from the bonded influence to the hydroxyapatite disk of coating saliva of the hibitane of collutory
It is active efficiency index in the oral cavity to the combination of hydroxyapatite that those skilled in the art know hibitane, because the effect of hibitane is attached to the ability of oral surfaces just because of it.
Following test method be used in the external test hibitane to hydroxyapatite in conjunction with level:
A) with the hydroxyapatite disk of known surface area under 37 ℃ in soaked overnight in sterifiltered blended people's saliva;
B) then disk was cleaned 15 seconds in 25 ml deionized water;
C) then every disk is soaked 60 seconds in 5 milliliters of test solutions after, washing 3 times (each 60 second time) in the deionized water of 25 milliliters of equal portions;
D) extract bonded hibitane and pass through high performance liquid chromatography (HPLC) analysis from disk then.
In order to estimate pH, contrast solution shown in table 1 and 2 and collutory have been prepared to the influence of hibitane in conjunction with level.Then product is estimated the hibitane associativity with listed method.What obtain the results are shown in Table 3.
Table 1
Standard %w/w
Collutory :- 1 2 3 4
The hibitane gluconate 0.00 0.03 0.06 0.09
0.1M sodium acetate buffer To 100.00 To 100.00 To 100.00 To 100.00
pH ?7.0 ?7.0 ?7.0 ?7.0
Table 2
Test collutory %w/w
Collutory :- ???5 ???6 ???7 ???8 ???9 ???10
The hibitane gluconate ???0.06 ???0.06 ???0.06 ???0.06 ???0.06 ???0.06
Cremaphor?RH60 ???0.225 ???0.225 ???0.225 ???0.225 ???0.225 ???0.225
Flavored oils ???0.12 ???0.12 ???0.12 ???0.12 ???0.12 ???0.12
Ethanol 96 ???6.50 ???6.50 ???6.50 ???6.50 ???6.50 ???6.50
Blue dyes solution ???0.10 ???0.10 ???0.10 ???0.10 ???0.10 ???0.10
Glycerol ???5.00 ???5.00 ???5.00 ???5.00 ???5.00 ???5.00
PVP ???5.00 ???5.00 ???5.00 ???5.00 ???5.00 ???5.00
Sodium acetate ???0.70 ???0.70 ???0.70 ???0.70 ???0.70 ???0.70
Sodium fluoride ???0.05 ???0.05 ???0.05 ???0.05 ???0.05 ???0.05
Saccharin sodium ???0.052 ???0.052 ???0.052 ???0.052 ???0.052 ???0.052
Acetic acid solution 50%w/w ???0.625 ???- ???- ???- ???- ???-
NaOH solution 10.2%w/w ???- ???- ???0.073 ???0.083 ???0.128 ???0.1625
Deionized water To 100.00 To 100.00 To 100.00 To 100.00 To 100.00 To 100.00
pH ???5.6 ??6.2 ???7.5 ???8.2 ???8.9 ???9.5
Table 3
Product pH Number of repetition On average in conjunction with horizontal μ g/cm
1 (standard) 7.0 10 0.32
2 (standards) 7.0 10 4.67
3 (standards) 7.0 8 8.18
4 (standards) 7.0 ?10 ?9.37
5 (collutory) 5.6 ?10 ?4.76
6 (collutory) 6.2 ?8 ?6.51
7 (collutory) 7.5 ?10 ?5.66
8 (collutory) 8.2 ?10 ?6.23
9 (collutory) 8.9 ?9 ?6.83
10 (collutory) 9.5 ?10 ?6.25
The result shows in conjunction with level and significantly improves to 6.2 (collutory 6) from 5.6 (collutory 5) with pH.But, do not observe that there were significant differences between the product along with pH rises to 9.5 (collutory 6-10) from 6.2.
If this experimental results show that the pH that makes collutory just can obtain enhanced in conjunction with level greater than 6.

Claims (8)

1. a mouthwash composition comprises biphase; First comprises on hibitane or a kind of stomatology acceptable carrier or excipient on acceptable its acid-addition salts and a kind of stomatology mutually, and second comprises acceptable carrier or excipient on polyvinyl pyrrolidone (PVP) and a kind of stomatology mutually; Described biphasely separately deposit before use, they provide pH single-phase between 6-10 to mix the back.
2. according to the compositions of claim 1, wherein hibitane obtains the pH that scope is 6.0-8.0 mutually with after PVP mixes mutually.
3. according to the compositions of claim 1 or 2, the pH of wherein said hibitane phase is not more than 6.
4. according to each compositions in claim 1 or 3, wherein the pH of PVP phase is 6.0-10.0.
5. according to the compositions of claim 4, thereby wherein said PVP comprises mutually on a kind of stomatology and to obtain required pH after acceptable buffer or pH regulator agent make it and hibitane mixes mutually.
6. according to each compositions in claim 1 or 5, wherein said PVP is at least 0.5% of described composition weight.
7. according to each compositions among the claim 1-6, also comprise a kind of ion and contain fluoride mixture.
8. according to each compositions among the claim 1-7, comprise a kind of nonionic, both sexes or cationic surfactant.
CN98803284A 1997-01-18 1998-01-14 Mouthwash composition Pending CN1250368A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9701031.8 1997-01-18
GBGB9701031.8A GB9701031D0 (en) 1997-01-18 1997-01-18 Composition

Publications (1)

Publication Number Publication Date
CN1250368A true CN1250368A (en) 2000-04-12

Family

ID=10806216

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98803284A Pending CN1250368A (en) 1997-01-18 1998-01-14 Mouthwash composition

Country Status (13)

Country Link
EP (1) EP1006991A1 (en)
JP (1) JP2001508785A (en)
CN (1) CN1250368A (en)
AR (1) AR011535A1 (en)
AU (1) AU6096998A (en)
BR (1) BR9806910A (en)
CA (1) CA2278237A1 (en)
CO (1) CO4920205A1 (en)
EA (1) EA199900547A1 (en)
GB (1) GB9701031D0 (en)
TW (1) TW518232B (en)
WO (1) WO1998031332A1 (en)
ZA (1) ZA98368B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050158349A1 (en) * 2004-01-20 2005-07-21 Jampani Hanuman B. Two-phase compositions containing alcohol
EP1797860A1 (en) * 2005-12-15 2007-06-20 JOHNSON & JOHNSON CONSUMER COMPANIES, INC. Two-phase compositions containing alcohol
IT1398050B1 (en) * 2010-02-02 2013-02-07 Lastri COMPOSITION FOR ORAL HYGIENE CONTAINING CLOREXIDINE AND A SYSTEM TO PREVENT THE FORMATION OF DARK PIGMENTS ON THE SURFACE OF TEETH AND ORAL MUCOS
CN111973484A (en) 2013-03-12 2020-11-24 普莱玛疗法公司 Dental compositions comprising chelating agents and bases
WO2015038689A2 (en) 2013-09-13 2015-03-19 3M Innovative Properties Company Cationic antiseptic compositions, method and kit
US10813892B2 (en) * 2016-05-24 2020-10-27 Carefusion 2200, Inc. Antiseptic solutions and applicators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9204410D0 (en) * 1992-02-29 1992-04-15 Smithkline Beecham Plc Method of treatment
DE69330797T2 (en) * 1993-01-19 2002-05-23 The Gillette Co., Boston Mouthwash

Also Published As

Publication number Publication date
GB9701031D0 (en) 1997-03-05
AU6096998A (en) 1998-08-07
CO4920205A1 (en) 2000-05-29
CA2278237A1 (en) 1998-07-23
TW518232B (en) 2003-01-21
JP2001508785A (en) 2001-07-03
WO1998031332A1 (en) 1998-07-23
BR9806910A (en) 2000-05-16
EA199900547A1 (en) 2000-06-26
ZA98368B (en) 1998-10-14
EP1006991A1 (en) 2000-06-14
AR011535A1 (en) 2000-08-30

Similar Documents

Publication Publication Date Title
JP3446214B2 (en) Liquid transparent oral composition
FI73882B (en) ANVAENDNING AV ETT YTAKTIVT SALT AV EN AMIN FOER STABILIZERING AV ETT TENN (II) SALT I EN ORAL KOMPOSITION.
JP2002255771A (en) Liquid composition for oral cavity not mixed with alcohol
Williams The antibacterial and antiplaque effectiveness of mouthwashes containing cetylpyridinium chloride with and without alcohol in improving gingival health
JP2002154936A (en) Hair cosmetic composition having dandruff formation- controlling effect
JPH0665034A (en) Detergent composition for oral cavity
JPH04257511A (en) Antibacterial oral composition free from pollution
CA2038251A1 (en) Antiseptic composition
CN1250368A (en) Mouthwash composition
US5182101A (en) Anti-plaque toothpaste
CA2530399A1 (en) Stable dentifrice compositions
CN114502136B (en) Oral care spray compositions comprising hexametaphosphate salt
JP3419124B2 (en) Oral composition
JPH08133911A (en) Antimicrobial composition
JPH1112144A (en) Liquid oral composition
JPS61272294A (en) Detergent composition
JP2003034615A (en) Pack cosmetic
JPH07267840A (en) Composition for oral cavity
JPH04159212A (en) Liquid transparent composition for oral cavity
JPS61272295A (en) Detergent composition
CN114430678B (en) Oral care compositions comprising hexametaphosphate and pigment
JP3838604B2 (en) Liquid oral composition
JPS61176518A (en) Mouth wash
JP7409759B2 (en) Oral composition
JP3702428B2 (en) Liquid oral composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication